科林電氣(603050.SH)收到150萬元財政補貼
格隆匯5月25日丨科林電氣(603050.SH)公佈,近日,公司收到石家莊市財政局、石家莊市科學技術局下發的《關於下達2020年大眾創業萬眾創新專項資金的通知》、收到河北省人民政府發佈的《關於印發河北省政府質量獎管理辦法的通知》,公司獲得石家莊市鹿泉區科學技術和工業信息化局撥付的支持“河北省智能配用電裝備產業技術研究院”專項補貼100萬元;獲得河北省市場監督管理局撥付的“2018年河北省政府質量獎”專項獎勵50萬元。目前,上述補貼150萬元已到賬。
根據《企業會計準則——政府補助》的相關規定,其中80萬元計入當期損益;70萬元用於購買相關設備確認為遞延收益,並在相關設備使用壽命內分攤計入損益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.